Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy

키워드

참고문헌 (31)

1. Thompson AM, "Neoadjuvant treatment of breast cancer", Ann Oncol, 23(Suppl 10), pp.x231~x236 (2012)
2. Moreno-Aspitia A, "Neoadjuvant therapy in early-stage breast cancer", Crit Rev Oncol Hematol, 82, pp.187~199 (2012)
3. Pierga JY, "Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response", Eur J Cancer, 39, pp.1089~1096 (2003)
4. Kuerer HM, "Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy", J Clin Oncol, 17, pp.460~469 (1999)
5. Fisher B, "Effect of preoperative chemotherapy on the outcome of women with operable breast cancer", J Clin Oncol, 16, pp.2672~2685 (1998)
6. Esserman LJ, "Accelerating identification and regulatory approval of investigational cancer drugs", JAMA, 306, pp.2608~2609 (2011)
7. Bonadonna G, "Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more", J Natl Cancer Inst, 82, pp.1539~1545 (1990)
8. Boughey JC, "Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer", Ann Surg, 244, pp.464~470 (2006)
9. Mamounas EP, "Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27", J Clin Oncol, 30, pp.3960~3966 (2012)
10. Carey LA, "American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome", J Natl Cancer Inst, 97, pp.1137~1142 (2005)
11. Ogston KN, "A new histological grading system to assess response of breast cancers to primary chemotherapy:prognostic significance and survival", Breast, 12, pp.320~327 (2003)
12. Abrial SC, "High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer", Breast Cancer Res Treat, 94, pp.255~263 (2005)
13. Pinder SE, "Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy", Histopathology, 50, pp.409~417 (2007)
14. Symmans WF, "Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy", J Clin Oncol, 25, pp.4414~4422 (2007)
15. Dash N, "Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer", AJR Am J Roentgenol, 173, pp.911~917 (1999)
16. Oh JL, "Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy", Cancer, 110, pp.2420~2427 (2007)
17. Schulz-Wendtland R, "Do tissue marker clips after sonographically or stereotactically guided breast biopsy improve follow-up of small breast lesions and localisation of breast cancer after chemotherapy?", Rofo, 174, pp.620~624 (2002)
18. 윤인영, "Ultrasonography-Guided Surgical Clip Placement for Tumor Localization in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer", Journal of Breast Cancer, 18(1), pp.44~49 (2015), 한국유방암학회
19. Margolin FR, "Metallic marker placement after stereotactic core biopsy of breast calcifications:comparison of two clips and deployment techniques", AJR Am J Roentgenol, 181, pp.1685~1690 (2003)
20. Provenzano E, "Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group", Mod Pathol, 28, pp.1185~1201 (2015)
21. Bossuyt V, "Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration", Ann Oncol, 26, pp.1280~1291 (2015)
22. Sharkey FE, "Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma", Mod Pathol, 9, pp.893~900 (1996)
23. Honkoop AH, "Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer", Am J Clin Pathol, 107, pp.211~218 (1997)
24. Diaz J, "Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease", Breast Cancer Res Treat, 138, pp.91~97 (2013)
25. Rajan R, "Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response", Cancer, 100, pp.1365~1373 (2004)
26. Fisher ER, "Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18", Cancer, 95, pp.681~695 (2002)
27. Leitner SP, "Predictors of recurrence for patients with small (one centimeter or less)localized breast cancer (T1a,b N0 M0)", Cancer, 76, pp.2266~2274 (1995)
28. Lee AK, "Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bNOMO):clinicopathologic features and outcome", Cancer, 79, pp.761~771 (1997)
29. Rabban JT, "Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease", Am J Surg Pathol, 33, pp.256~263 (2009)
30. Colleoni M, "Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer", Ann Oncol, 18, pp.1632~1640 (2007)
31. Sahoo S, "Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting", Arch Pathol Lab Med, 133, pp.633~642 (2009)

관련 논문AI추천